Nuveen
WHWK

Nuveen’s Whitehawk Therapeutics WHWK Stock Holding History

Nuveen’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+43,799
New +$182K ﹤0.01% 3643
2024
Q2 		– Sell
-20,913
Closed -$48.9K – 3434
2024
Q1 		$48.9K Hold
20,913
– – ﹤0.01% 3269
2023
Q4 		$42.2K Hold
20,913
– – ﹤0.01% 3307
2023
Q3 		$101K Hold
20,913
– – ﹤0.01% 3121
2023
Q2 		$143K Hold
20,913
– – ﹤0.01% 3136
2023
Q1 		$151K Hold
20,913
– – ﹤0.01% 3022
2022
Q4 		$268K Hold
20,913
– – ﹤0.01% 3008
2022
Q3 		$296K Hold
20,913
– – ﹤0.01% 3049
2022
Q2 		$258K Buy
+20,913
New +$311K ﹤0.01% 3121

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's WHWK Position: Q2 2026 in Review

Nuveen opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 43,799 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #3643 among its holdings. This is a return to the name: Nuveen previously reported a position in WHWK as recently as Q1 2024.

Nuveen first reported a position in WHWK in Q2 2022 and has held it in 9 quarters since. The position peaked at $296K in Q3 2022. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Nuveen held 43,799 shares of Whitehawk Therapeutics worth $201K as of Q2 2026.
  • Whitehawk Therapeutics was a new Nuveen position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3643 holding.
  • Nuveen first reported a position in Whitehawk Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • Nuveen's Whitehawk Therapeutics position peaked at $296K in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.